Clinical Report: Efficacy and Safety of Cerebral Embolic Protection Devices in TAVR

Overview

This meta-analysis evaluated the efficacy and safety of cerebral embolic protection (CEP) devices during transcatheter aortic valve replacement (TAVR) across nine randomized controlled trials. The findings indicate that CEP devices do not significantly reduce the risk of all-cause stroke or other major complications compared to no protection.

Background

Cerebrovascular events are a significant complication of TAVR, leading to increased morbidity and mortality. As TAVR expands to younger and lower-risk patients, effective strategies for stroke prevention are critical. The clinical benefit of CEP devices remains uncertain, prompting this comprehensive meta-analysis to clarify their impact on patient outcomes.

Data Highlights

Key Findings

• CEP devices did not significantly reduce the risk of all-cause stroke (RR 0.92; 95% CI 0.73–1.14; p = 0.43).
• No significant differences were observed in disabling stroke, non-disabling stroke, or cardiovascular mortality between CEP and control groups.
• CEP devices did not reduce major adverse cardiovascular and cerebrovascular events or major bleeding complications.
• Results were consistent across subgroups, including different types of CEP devices (Sentinel and TriGuard).
• Current guidelines recommend selective use of CEP devices in high-risk populations, but routine use is not endorsed.

Clinical Implications

The findings suggest that the routine use of CEP devices during TAVR may not provide additional benefits in reducing stroke risk. Clinicians should consider these results when making decisions about stroke prevention strategies in TAVR patients, particularly in lower-risk populations.

Conclusion

This meta-analysis indicates that CEP devices do not significantly improve outcomes related to stroke or major complications in TAVR patients. Further research is needed to explore potential benefits in specific high-risk subsets.

Related Resources & Content

1. Clinical Research in Cardiology, 2025 -- Utilization of Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Linked to Reduced Stroke Incidence in a High-Volume Medical Facility
2. Clinical Research in Cardiology, 2020 -- Comparison of Antithrombotic Regimens With and Without Clopidogrel Following Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Trials
3. Clinical Research in Cardiology, 2020 -- Incidence of Stroke Within 30 Days Following Transfemoral Transcatheter Aortic Valve Implantation: A Meta-Analysis Comparing Self-Expandable and Balloon-Expandable Valve Prostheses
4. 2025 ESC/EACTS Guidelines for the management of valvular heart disease
5. Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement - American College of Cardiology
6. Routine Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials - ScienceDirect
7. Clinical Research in Cardiology — Decreased Need for Permanent Pacemaker Insertion with Cusp Overlap Technique in Transcatheter Aortic Valve Replacement: A Meta-Analytical Review
8. ESC Guidelines on Valvular Heart Disease
9. American College of Cardiology - PROTECTED TAVR Trial
10. Routine Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials - ScienceDirect